Dole / Boston Scientific / UNeMed Corporation / D. / UNeMed Before / /
Continent
America / /
Country
United States / /
Currency
USD / /
Facility
University of Nebraska Medical Center / University of Nebraska / /
IndustryTerm
information technology software / biomedical and clinical technology areas / innovations and technologies / university technology transfer offices / biotechnology / surgical device / invasive radiofrequency ablation tool / technology transfer efforts / patent law / healthcare / technology transfer process / university technology transfer industry / technology licensing entity / technology transfer / /
MedicalCondition
solid cancer tumors / /
Organization
the University of Nebraska / Congress / American Intellectual Property Law Association / United States House of Representatives / United States Patent and Trademark Office / FDA / Biotechnology Industry Organization / Commerce / Manufacturing / and Trade Committee on Energy / Trade Committee on Energy / Subcommittee on Commerce / Nebraska Medical Center / /
Person
Michael J. Dixon / Robert LeVeen / Schakowsky / Terry / Randy Fox / /
Position
counsel / Introduction Chairman / CEO / Chairman / President / President and CEO / Ph. President / /
ProvinceOrState
Nebraska / /
Technology
information technology / biotechnology / University technology / /
Statement of Michael J. Dixon, Ph.D. President and CEO, UNeMed Before the Subcommittee on Commerce, Manufacturing, and Trade Committee on Energy and Commerce